#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	17222	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2323	890.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1489	1489	C	1123	C,T,G	1121,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29180	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4244	856.5	0	.	n	.	0	T695C	SNP	695	695	T	1338	1338	C	1031	C,T,A	1027,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29180	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4244	856.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1980	1980	A	1104	A,G,C	1099,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29180	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4244	856.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2614	2614	C	1105	C,T,A,G	1099,2,2,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29180	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4244	856.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2688	2688	A	1020	A,T,G,C	1016,1,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29180	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4244	856.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	3240	3240	C	1036	C,G	1034,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	27	49056	blaTEM	861	861	100.0	blaTEM.l15.c4.ctg.1	1971	3094.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2588	folP	855	855	100.0	folP.l15.c4.ctg.1	2005	160.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1308	1310	AGC	253;252;253	A;G;C	253;252;253	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_Z_01155	gyrA.WHO_Z_01155	1	1	27	5842	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3919	185.8	1	SNP	p	S91F	1	.	.	271	273	TTC	850	852	TTC	203;207;208	T,A;T,C;C,A	202,1;206,1;207,1	gyrA.WHO_Z_01155:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_Z_01155	gyrA.WHO_Z_01155	1	1	27	5842	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3919	185.8	1	SNP	p	D95N	1	.	.	283	285	AAC	862	864	AAC	221;225;224	A;A;C,T	221;225;223,1	gyrA.WHO_Z_01155:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_Z_01155	gyrA.WHO_Z_01155	1	1	27	5842	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3919	185.8	1	SNP	p	N95G	0	.	.	283	285	AAC	862	864	AAC	221;225;224	A;A;C,T	221;225;223,1	gyrA.WHO_Z_01155:1:1:N95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	2278	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1815	156.3	1	SNP	p	G45D	0	.	.	133	135	GGC	756	758	GGC	253;253;257	G,A;G;C,T	252,1;253;256,1	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1142	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1588	89.7	0	.	n	.	0	A197.	DEL	197	197	A	851	851	A	225	A	225	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5822	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3492	207.7	1	SNP	p	D86N	0	.	.	256	258	GAC	857	859	GAC	227;225;223	G,A;A;C,A	226,1;225;222,1	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5822	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3492	207.7	1	SNP	p	S88P	0	.	.	262	264	TCC	863	865	TCC	221;222;224	T;C;C	221;222;224	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4854	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3189	189.5	0	.	p	.	0	D437N	NONSYN	1309	1311	GAT	1919	1921	AAT	253;253;253	A,G,T;A;T	250,1,1;252;252	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4854	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3189	189.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1838	1840	GGC	225;223;223	G;G;C	225;223;223	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4562	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2962	192.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1592	1594	GCA	280;284;287	G;C,T,A;A	280;282,1,1;287	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4562	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2962	192.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1595	1597	ATC	289;290;289	A,T;T;C,G,A	288,1;290;287,1,1	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4562	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2962	192.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1607	1609	GTG	292;293;292	G,T;T;G	291,1;293;292	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4562	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2962	192.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1607	1609	GTG	292;293;292	G,T;T;G	291,1;293;292	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4562	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2962	192.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2111	2113	ACC	263;267;264	A,G;C;C,T,A	262,1;267;262,1,1	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4562	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2962	192.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2165	2167	GCG	261;262;260	G,C;C;G,C	260,1;262;259,1	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4562	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2962	192.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2165	2167	GCG	261;262;260	G,C;C;G,C	260,1;262;259,1	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4562	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2962	192.1	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2288	2290	GGC	260;260;259	G,A;G;C,T	258,1;259;258,1	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4562	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2962	192.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2297	2299	GGC	267;268;267	G;G,C;C,G	267;267,1;266,1	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4562	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2962	192.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2315	2317	CCG	264;262;257	C,G;C,T;G,A	261,3;261,1;255,2	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6540	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3567	228.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1876	1878	CCG	255;254;252	C;C;G	255;254;252	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2634	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2367	138.7	0	.	p	.	0	S22G	NONSYN	64	66	AGC	683	685	GGC	200;198;197	G,A;G,A;C	198,2;197,1;197	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2634	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2367	138.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	865	865	C	188	C	188	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3448	porB1b	1041	1041	97.61	porB1b.l15.c30.ctg.1	2247	191.0	0	.	p	.	0	T26A	NONSYN	76	78	ACC	908	910	GCC	293;295;294	G;C,T,A;C,G	292;292,1,1;292,1	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3448	porB1b	1041	1041	97.61	porB1b.l15.c30.ctg.1	2247	191.0	0	.	p	.	0	K41D	NONSYN	121	123	AAA	953	955	GAC	286;285;284	G,A;A,G;C	285,1;284,1;284	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3448	porB1b	1041	1041	97.61	porB1b.l15.c30.ctg.1	2247	191.0	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	1259	1261	CAA	247;250;248	C,A,T;A;A,C	244,2,1;250;247,1	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3448	porB1b	1041	1041	97.61	porB1b.l15.c30.ctg.1	2247	191.0	0	.	p	.	0	R187Q	NONSYN	559	561	CGA	1391	1393	CAA	307;304;303	C,T;A,G;A	306,1;303,1;303	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3448	porB1b	1041	1041	97.61	porB1b.l15.c30.ctg.1	2247	191.0	0	.	p	.	0	N189S	NONSYN	565	567	AAC	1397	1399	AGC	305;303;302	A;G,T;C	305;302,1;302	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3448	porB1b	1041	1041	97.61	porB1b.l15.c30.ctg.1	2247	191.0	0	.	p	.	0	I209M	NONSYN	625	627	ATC	1457	1459	ATG	288;286;283	A,T;T,G;G	287,1;285,1;283	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3448	porB1b	1041	1041	97.61	porB1b.l15.c30.ctg.1	2247	191.0	0	.	p	.	0	.	MULTIPLE	632	633	GC	1465	1468	AGAT	286;288;289;288	A,T;G;A;T,G	285,1;288;289;287,1	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3448	porB1b	1041	1041	97.61	porB1b.l15.c30.ctg.1	2247	191.0	0	.	p	.	0	Q213L	NONSYN	637	639	CAG	1472	1474	TTA	298;294;291	T,G;T,G;A	297,1;293,1;291	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3448	porB1b	1041	1041	97.61	porB1b.l15.c30.ctg.1	2247	191.0	0	.	p	.	0	S216I	NONSYN	646	648	AGC	1481	1483	ATC	282;279;281	A,G;T,A;C	281,1;278,1;281	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3448	porB1b	1041	1041	97.61	porB1b.l15.c30.ctg.1	2247	191.0	0	.	p	.	0	G253R	NONSYN	757	759	GGA	1592	1594	AGA	289;293;292	A;G;A	288;292;292	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3448	porB1b	1041	1041	97.61	porB1b.l15.c30.ctg.1	2247	191.0	0	.	p	.	0	R256S	NONSYN	766	768	CGT	1601	1603	AGT	292;291;292	A,C,G;G,A;T	290,1,1;290,1;292	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3448	porB1b	1041	1041	97.61	porB1b.l15.c30.ctg.1	2247	191.0	0	.	p	.	0	D293S	NONSYN	877	879	GAT	1712	1714	AGT	308;309;311	A,C;G,A;T	307,1;308,1;311	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3448	porB1b	1041	1041	97.61	porB1b.l15.c30.ctg.1	2247	191.0	0	.	p	.	0	N295D	NONSYN	883	885	AAC	1718	1720	GAC	307;304;303	G;A;C	307;304;303	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3448	porB1b	1041	1041	97.61	porB1b.l15.c30.ctg.1	2247	191.0	1	SNP	p	G120K	1	.	.	358	360	AAG	1190	1192	AAG	283;282;282	A,G;A;G	282,1;282;282	porB1b.WHO_O_01976:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3448	porB1b	1041	1041	97.61	porB1b.l15.c30.ctg.1	2247	191.0	1	SNP	p	A121D	1	.	.	361	363	GAC	1193	1195	GAC	282;284;286	G,C;A;C,T	281,1;284;285,1	porB1b.WHO_O_01976:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3448	porB1b	1041	1041	97.61	porB1b.l15.c30.ctg.1	2247	191.0	1	SNP	p	D121N	0	.	.	361	363	GAC	1193	1195	GAC	282;284;286	G,C;A;C,T	281,1;284;285,1	porB1b.WHO_O_01976:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	539	11446	rpoB	4179	4179	99.95	rpoB.l15.c4.ctg.1	5272	270.2	0	.	p	.	0	S539G	NONSYN	1615	1617	AGT	2189	2191	GGT	245;245;244	G,A;G,A;T,C	243,2;244,1;243,1	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1704	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1521	139.6	1	SNP	p	V57M	1	.	.	169	171	ATG	792	794	ATG	298;298;298	A;T;G,C	298;298;297,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	27	15450	tetM	1920	1920	100.0	tetM.l15.c4.ctg.1	3080	624.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Tetracycline resistance
